If you’ve ever wondered how widespread chronic illness truly is in the U.S., the latest numbers are eye-opening. 129 million Americans– nearly one-third of the country are living with at least one chronic disease. For them, managing symptoms, medications, lifestyle changes, and regular check-ups isn’t a temporary challenge; it’s a lifelong journey.
FDA’s new initiative– TEMPO
This is why the FDA’s newly launched Technology Enabled Meaningful Patient Outcomes (TEMPO) pilot feels like a turning point. It isn’t just an example of healthcare going digital. It’s a real boon for people dealing with chronic illness, offering tools that fit into everyday life while still safeguarding patient safety.
The TEMPO pilot introduces a risk-based enforcement approach for digital health devices aimed at improving outcomes in several major areas: cardio-kidney-metabolic health, musculoskeletal issues, and behavioral health conditions. These span a range of problems from prediabetes & back strain to more complex heart failure and depression.
TEMPO in a gist
In simple terms, TEMPO encourages the development and use of digital tools from therapeutic apps to remote monitoring systems that people can use right where they are. This shift brings healthcare out of the clinic and into homes, workplaces, and daily routines.
A key feature of the pilot is flexibility. Manufacturers participating in TEMPO may request that the FDA exercise enforcement discretion for certain regulatory requirements, such as premarket authorization. In return, they must collect and share real-world performance data from people actually using the devices.
This creates a win-win environment:
- Patients get faster access to innovative technologies, and
- the FDA gains valuable insights into how these devices perform in everyday life
- It also aligns perfectly with the rapid, iterative nature of digital health development.
Key problems it can solve
The devices included in the pilot may be designed for a wide range of conditions- from low-acuity cardiometabolic issues like prediabetes, to more serious challenges like heart failure, chronic back pain, and depression. Digital tools in these areas have already shown tremendous potential to help people track symptoms, monitor health trends, stick to treatment plans, and even catch red flags early.
With TEMPO, the impact could scale dramatically.
Making your home a healthcare hub
TEMPO also ties into a larger vision- the FDA’s Home as a Health Care Hub initiative. This program reimagines modern healthcare by bringing reliable, safe, effective tools into the places where people already live, work, and play. Instead of occasional snapshots during clinic visits, chronic illness care becomes continuous, personalized, and convenient.
For the millions of Americans managing long-term health conditions, this approach could reduce complications, lower hospital visits, improve quality of life, and make care far more accessible.
In many ways, the launch of TEMPO marks a major shift in the agency’s strategy:
- supporting technology-enabled care,
- strengthening chronic disease management, and
- widening access to digital health solutions nationwide.
With 129 million people in need of better support, the timing could not be more urgent or more promising.